Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0354678 Use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating Lax vagina...
The mixture of un-refined salt and sugar in the manufacture of a medicament employed for treating lax vagina syndrome or colpoxerosis disease in a mammal....
2017/0354677 MAGNESIUM DELIVERY SYSTEM
A roll-on product, including magnesium hydroxide; propanediol; glycerin and glycine soja (soybean), is advantageously used as a deodorant and/or for...
2017/0354676 Composition for the Relief of Dry Mouth
A mucoadhesive formulation containing a clathrate host that encloses water molecules provides an effective means for, not only providing moisture to, and...
2017/0354675 CHONDROITIN SULFATE DERIVATIVE AND AGENT FOR TREATING BLADDER DISEASES
Provided is a compound in which a group derived from chondroitin sulfate and a group derived from a steroid are covalently bonded together via a spacer...
2017/0354674 ADMINISTRATION OF SYNERGISTIC AMOUNTS OF MODIFIED CITRUS PECTIN AND HONOKIOL TO TREAT INFLAMMATION AND...
A method of inhibiting or reducing inflammation in a mammal comprises administering MCP or similar Gal-3 binding moiety with honokiol in a range of about...
2017/0354673 OLIGONUCLEOTIDE HAVING NON-NATURAL NUCLEOTIDE AT 5'-TERMINAL THEREOF
An oligonucleotide having a nucleotide residue or a nucleoside residue represented by formula (I) {wherein X.sup.1 is an oxygen atom or the like, R.sup.1 is...
2017/0354672 COMPOSITIONS FOR THE DELIVERY OF TRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH
In some aspects, the present disclosure provides a nanoparticle composition comprising tRNA and an aminolipid delivery compound. The aminolipid delivery...
2017/0354671 TREATMENT OF OCULAR DISORDERS
The invention includes a method of treating an intraocular disorder in a mammal, the method comprising administering to the mammal a Very Late Antigen-4...
2017/0354670 PRODUCT COMPRISING GLUCOSAMINE FOR EXTERNAL APPLICATION
The present disclosure relates to, inter alia, a topical fluid application apparatus comprising a solution of glucosamine or a pharmaceutically acceptable salt...
2017/0354669 DISRUPTION OF THE INTERACTION BETWEEN AMYLOID BETA PEPTIDE AND DIETARY LIPIDS
The present invention relates to methods of treating neurodegenerative disorders associated with Alzheimer's disease (AD), Parkinson's disease (PD) and...
2017/0354668 Synthesis Method For Improved Tenofovir Disoproxil Fumarate Using Ion-Exchange Resin And Method For Preparing...
The present invention relates to a synthesis method of preventing the formation of impurities and byproducts in the synthesis of tenofovir disoproxil fumarate...
2017/0354667 COMPOSITION AND METHOD FOR TREATING BIPOLAR DISORDER
Disclosed is a composition suitable for oral administration and capable of treating individuals suffering from unipolar disorder, bipolar disorder and/or...
2017/0354666 COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS
One aspect of the invention provides a method for treatment of a lysosomal storage disorder. The method may include administering to a subject in need of such...
2017/0354665 Abiraterone Acetate Formulation
Pharmaceutical compositions, including unit dosage forms, comprising fine particle abiraterone acetate with or without an antioxidant and or a sequesting agent...
2017/0354664 Prodrugs of 17.BETA.-HSD1-inhibitors
The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof wherein R1 to R4 are as defined in the claims. The invention...
2017/0354663 Steroidal Compositions
Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals. Also...
2017/0354662 METHODS AND COMPOSITIONS FOR TREATING MIGRAINES USING NORIBOGAINE
This invention provides methods and compositions for treating or preventing migraine headache and/or symptoms thereof in a subject. The method comprises...
2017/0354661 Finafloxacin For Use In The Treatment Of Urinary Tract Infections
It was found that finafloxacin eradicates pathogens from patients suffering from bacterial infections like urinary tract infections and pyelonephritis more...
2017/0354660 Medical Use of Pharmaceutical Combination or Composition
The present invention relates to a certain DPP-4 inhibitor for use in combination with metformin in CKD patients.
2017/0354659 COMPOSITIONS CONTAINING DEFINED CAFFEINE AND THEOBROMINE LEVELS WITH ENHANCED COGNITIVE PROPERTIES
The invention includes compositions and methods for improving cognitive function or reducing the anxiety effects of caffeine cravings. Caffeine and theobromine...
2017/0354658 FORMULATION INHIBITING EFFECTS OF LOW ACID ENVIRONMENT
The present invention is directed to formulations comprising PVP polymer, a dispersion of a compound of Formula I (API), and citric acid, which formulations...
2017/0354657 METHOD OF TREATING PANCREATIC CANCER
The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or...
2017/0354656 Quinazoline Compounds
Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and...
2017/0354655 TLR INHIBITOR AND BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS
Provided are compositions for and methods of treating a B-cell malignancy in a subject in need thereof, by administering to the subject a therapeutically...
2017/0354654 PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND IRRITANT AGENT
Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an...
2017/0354653 BUPRENORPHINE DOSING REGIMENS
The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the...
2017/0354652 ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control...
2017/0354651 Treatment Of Neurodegenerative Diseases With Combination Of Laquinimod And Fingolimod
This invention provides a method of treating a subject afflicted with a neurodegenerative disease comprising periodic administration of an amount of laquinimod...
2017/0354650 QUINOLINE DERIVATIVES FOR INHIBITING HISTONE METHYLTRANSFERASES AND USE THEREOF
The present disclosure relates to a quinoline derivative which inhibits the activity of histone methyltransferases (ESET/SETDB1) specific for the histone...
2017/0354649 THERAPEUTIC USES OF BERBERINE FORMULATIONS
Uses of pharmaceutical compositions comprising berberine for treatment of dermatologic toxicities and other skin disorders.
2017/0354648 1,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN
The present invention relates to compounds having dual pharmacological activity towards both the sigma (.sigma.) receptor, and the .mu.-opiod receptor and more...
2017/0354647 Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a...
The present invention provides uses of a glucokinase activator in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose,...
2017/0354646 METHOD FOR TREATING DISORDERS ASSOCIATED WITH GLOMERULAR FUNCTION
Methods of administering and pharmaceutical compositions of a biphenyl sulfonamide compound which is a dual angiotensin and endothelin receptor antagonist are...
2017/0354645 METHODS FOR TREATING KIDNEY DISORDERS
Provided are methods and formulations for treating kidney disorders in man and animals, which include the use of a compound of the Formula I and ...
2017/0354644 Polymorphic Forms of Methyl((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)- ...
Amorphous methyl((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-((methoxycarbo- nyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenyly- ...
2017/0354643 TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF
The invention provides trifluoromethyl pyrazolyl guanidine compounds that inhibit F.sub.1F.sub.0-ATPase, and methods of using trifluoromethyl pyrazolyl...
2017/0354642 ENVENOMATION THERAPIES AND RELATED PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND KITS
The invention provides methods of treatment, pharmaceutical compositions, systems and kits appropriate for first line and/or adjunct therapy with antivenom...
2017/0354641 2,3-DIHYDRO-1H-INDOLE COMPOUNDS
The present invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising the compounds, and methods of using the...
2017/0354640 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PRE-DIABETES, DIABETES AND METABOLIC SYNDROME
The disclosure provides thiol-containing alkyl fatty acid and vitamin D compound formulations for intravenous, parenteral or oral administration. The...
2017/0354639 DITERPENOID DERIVATIVES AND METHODS OF USE THEREOF
Provided herein are compounds of formula (I) and compositions containing the compounds. The compounds and compositions are useful in the methods of treating,...
2017/0354638 BIXA ORELLANA COMPOSITION FOR THE TREATMENT MACULAR DEGENERATION
A method for photoprotection of the retinal pigmentary epithelium in a mammal includes administering an effective amount of a composition containing an extract...
2017/0354637 FIBROTIC TISSUE STABILIZED BY CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEA
The present invention relates to administration or application of a crosslink inducing agent to a subject following a stiffening procedure to the respiratory...
2017/0354636 METHODS FOR INHIBITING TUMORS AND DRUG RESISTANCE
Compositions and methods are provided for improving the treatment of tumors by inhibiting cytochrome P450 enzymes ("CYPs") expressed by tumors. Inhibition of...
2017/0354635 METHODS FOR TREATING ATRIAL FIBRILLATION
The subject invention provides methods for reducing stroke rate, methods for preventing atrial remodeling, and methods for reversing atrial remodeling by...
2017/0354634 COMBINATIONS OF PROSTAGLANDINS AND NITRIC OXIDE DONORS
The present invention relates to compositions for treating glaucoma and elevated ocular pressure. The compositions comprise a nitric oxide releasing isomannide...
2017/0354633 APPLICATION OF DERIVATIVE OF CLOSTRIDIUM GHONII
Application of Derivatives of Clostridium ghonii, especially in the application of Derivatives of Clostridium ghonii MW-DCG-HNCv-18 in preparation of medicines...
2017/0354632 METHODS OF TREATING UREA CYCLE DISORDERS
The present disclosure provides novel methods for determining an effective dosage of a PAA prodrug and for treating a UCD that incorporate body surface area...
2017/0354631 METHODS OF TREATING UREA CYCLE DISORDERS
The present disclosure provides novel methods for determining an effective dosage of a PAA prodrug and for treating a UCD that incorporate body surface area...
2017/0354630 Methods of Treating Multiple Sclerosis
Provided herein are methods of treating multiple sclerosis with a fumarate, wherein the fumarate is a dialkyl fumarate, a monoalkyl fumarate, a combination of...
2017/0354629 Method And Compositions For Treating Skin
A composition and method for increasing and/or synchronizing per1 gene expression in skin cells having decreased, irregular, or asynchronous per1 gene...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.